Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin Succinate in Overactive Bladder (VIBRANT)
NCT00573508Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in overactive bladder (OAB) comparing Placebo with Solifenacin Succinate (2 arms). Primary endpoint: Overactive Bladder Questionnaire Symptom Bother Score at 12 weeks. Started Aug 2007; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00573508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573508.